Pharmacology, Toxicology and Pharmaceutical Science
Liposome
100%
Neoplasm
84%
Rhenium 188
74%
Malignant Neoplasm
63%
Colon Carcinoma
48%
Tumor Growth
47%
Combination Therapy
44%
Epidermal Growth Factor Receptor
44%
Pharmacokinetics
43%
Chimeric Protein
32%
Biodistribution
31%
Fluorouracil
28%
Flucytosine
24%
Dosimetry
20%
Ovary Cancer
20%
Solid Malignant Neoplasm
17%
Non Small Cell Lung Cancer
17%
Hepatitis C Virus
17%
Adrenergic Receptor
17%
Daclatasvir
17%
Endostatin
17%
Receptor
15%
DNA Immunization
14%
Vasculotropin
14%
Guanosine Triphosphate
14%
Breast Cancer
14%
Carcinomatous Peritonitis
13%
Cytosine Deaminase
13%
Cytotoxic T Lymphocyte Antigen 4
12%
Liver Cell Carcinoma
12%
Luciferase
11%
Cancer Model
11%
Chemotherapy
11%
Prodrug
11%
Mouse Model
11%
Metastasis
11%
Interferon
11%
Tumor Model
10%
Guanine Nucleotide Binding Protein
10%
Drug Resistance
10%
Renal Cell Carcinoma
10%
Drug Delivery System
9%
Hypoxia Inducible Factor 1
9%
Antivirus Agent
8%
Saikosaponin
8%
Lung Tumor
8%
Aromatic Hydrocarbon Receptor
8%
Imipramine
8%
Diabetic Retinopathy
8%
Pigmented Villonodular Synovitis
8%
Keyphrases
188Re-liposome
63%
Therapeutic Efficacy
41%
Pharmacokinetics
40%
5-fluorouracil (5-FU)
38%
Tumor Growth
36%
188Re
36%
Tumor
34%
Fusion Protein
33%
Biodistribution
31%
Liposomes
29%
Colon Cancer
29%
Cancer Cells
28%
Hepatitis C Virus
26%
Regulator of G Protein Signaling
26%
Albumin-binding Domain
24%
Radiotherapy
23%
Taiwan
23%
Epidermal Growth Factor Receptor
23%
Dosimetry
21%
CT26
21%
Ovarian Cancer
20%
Interleukin-15 (IL-15)
19%
Inhibitory Effect
19%
Cationic Liposomes
17%
Human EGF
17%
5-fluorocytosine
17%
Cancer Stem Cells
17%
GTP Hydrolysis
17%
Adrenergic Receptors
17%
Honokiol
17%
Recombinant Human
17%
Endostatin
17%
Daclatasvir
17%
Stereotactic Ablative Radiotherapy
17%
Lung
16%
NS5A
16%
Overexpressing
14%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
14%
RGS4
14%
Phosphorylation
13%
Peritoneal Carcinomatosis
13%
Hepatocellular Carcinoma
12%
Interferon-α (IFN-α)
12%
Deactivation
12%
Endothelial Cells
12%
Definitive Radiotherapy
11%
Chemotherapy
11%
Tumor Inhibition
11%
Prodrug Systems
11%
DNA Vaccine
11%